Dr Reddys Laboratories Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹8,753.40 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.85 per cent from ₹8,828.30 crore. This corresponds to a year-on-year *(YoY) growth of 4.44 per cent.
Operating Profit
Operating Profit stands at ₹1,914.50 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 7.83 per cent from ₹2,077.20 crore. This corresponds to a year-on-year *(YoY) decline of 15.76 per cent.
PBDT
PBDT stands at ₹2,064.20 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 8.23 per cent from ₹2,249.40 crore. This corresponds to a year-on-year *(YoY) decline of 12.00 per cent.
Profit Before Tax
Profit Before Tax stands at ₹1,543.20 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 11.55 per cent from ₹1,744.80 crore. This corresponds to a year-on-year *(YoY) decline of 17.67 per cent.
Net Profit
Net Profit stands at ₹1,189.60 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 11.01 per cent from ₹1,336.80 crore. This represents a 15.28 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Dr Reddys Laboratories Ltd News
Dr Reddys Laboratories Ltd Earnings
- YOY
- QOQ
Dr Reddys Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Dr Reddys Laboratories Ltd Research Reports
Dr Reddys Laboratories Ltd Financial Reports
Dr Reddys Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Dr Reddy's Labs | 1.42% | 9.66% | 6.37% | 10.43% | 6.54% | 13.46% |
| Sun Pharma.Inds. | 7.03% | 3.87% | -1.34% | 9.09% | 1.01% | -3.93% |
| Divi's Lab. | 1.44% | 2.58% | 8.48% | 6.83% | -0.90% | 5.55% |
| Torrent Pharma. | 2.25% | 3.13% | -0.29% | 7.24% | 16.91% | 26.70% |
| Lupin | 1.39% | 0.89% | 0.67% | 9.21% | 18.97% | 12.61% |
| Cipla | 1.61% | 6.52% | 7.56% | -0.36% | -16.78% | -14.63% |
| Mankind Pharma | 0.27% | 1.69% | 13.31% | 8.12% | -7.02% | -11.12% |
Company Info
Company Information
Co-Chairman & Managing Director : G V Prasad
Executive Chairman : K Satish Reddy
Independent Director : Shikha Sanjaya Sharma
Independent Director : Leo Puri
Independent Director : K P Krishnan
Independent Director : Pennv Wan
Company Sec. & Compli. Officer : K Randhir Singh
Independent Director : Arun M. Kumar
Independent Director : Claudio Albrecht
Independent Director : Sanjiv Mehta
Independent Director : Alpna Seth